Li YL, Li D, Liu B, Wang WJ, Wang W, Wang YZ. Safety and efficacy of percutaneous transhepatic balloon dilation in removing common bile duct stones: A systematic review. World J Meta-Anal 2019; 7(4): 162-169 [DOI: 10.13105/wjma.v7.i4.162]
Corresponding Author of This Article
Yu-Liang Li, MD, PhD, Chief Doctor, Doctor, Professor, Department of Interventional Medicine, The Second Hospital of Shandong University, No. 247, Beiyuan Street, Jinan 250033, Shangdong Province, China. lyl.pro@sdu.edu.cn
Research Domain of This Article
Medicine, Research & Experimental
Article-Type of This Article
Systematic Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Meta-Anal. Apr 30, 2019; 7(4): 162-169 Published online Apr 30, 2019. doi: 10.13105/wjma.v7.i4.162
Safety and efficacy of percutaneous transhepatic balloon dilation in removing common bile duct stones: A systematic review
Yu-Liang Li, Dong Li, Bin Liu, Wu-Jie Wang, Wei Wang, Yong-Zheng Wang
Yu-Liang Li, Dong Li, Bin Liu, Wu-Jie Wang, Wei Wang, Yong-Zheng Wang, Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan 250033, Shandong Province, China
Author contributions: Li YL initiated the study and secured the funding; Li D and Liu B designed the review and carried out the analysis; Li D drafted the initial manuscript and Li YL and Wang W revised the manuscript; Wang WJ and Wang YZ participated in developing the manuscript; all authors reviewed and approved the final manuscript as submitted.
Supported bythe Natural Science Foundation of Shandong Province, Nos. 2014ZRE27479, ZR2018PH032, and ZR2018PH033; and the National Natural Science Foundation of China, No. 6167276.
Conflict-of-interest statement: There are no conflicts of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Yu-Liang Li, MD, PhD, Chief Doctor, Doctor, Professor, Department of Interventional Medicine, The Second Hospital of Shandong University, No. 247, Beiyuan Street, Jinan 250033, Shangdong Province, China. lyl.pro@sdu.edu.cn
Telephone: +86-531-8524777
Received: March 12, 2019 Peer-review started: March 13, 2019 First decision: March 27, 2019 Revised: April 3, 2019 Accepted: April 18, 2019 Article in press: April 18, 2019 Published online: April 30, 2019 Processing time: 49 Days and 19 Hours
Core Tip
Core tip: Endoscopic treatment for common bile duct (CBD) stones has been widely accepted. However, for specific patients, such as those with gastrointestinal anatomical changes, duodenal diverticulum, esophageal varices, or other conditions, endoscopic treatment is unsuitable and difficult to perform. Under these circumstances, it has been shown that percutaneous transhepatic balloon dilation (PTBD) can remove CBD stones via a percutaneous transhepatic route after papilla dilation. However, no review on this technique has been published. Therefore, we performed a systematic review to confirm the safety and efficacy of PTBD in removing CBD stones in terms of the key outcomes, success rate, reasons for failure, and procedure-related complications.
